BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 21294122)

  • 21. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
    Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
    Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.
    Khammanivong A; Gopalakrishnan R; Dickerson EB
    Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.
    Muhammad N; Bhattacharya S; Steele R; Phillips N; Ray RB
    Clin Cancer Res; 2017 Jun; 23(12):3120-3128. PubMed ID: 27965308
    [No Abstract]   [Full Text] [Related]  

  • 25. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
    Lim YC; Kang HJ; Moon JH
    Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
    Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
    Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation.
    Yu CC; Chen YW; Chiou GY; Tsai LL; Huang PI; Chang CY; Tseng LM; Chiou SH; Yen SH; Chou MY; Chu PY; Lo WL
    Oral Oncol; 2011 Mar; 47(3):202-10. PubMed ID: 21292542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.
    Ganguli-Indra G; Wasylyk C; Liang X; Millon R; Leid M; Wasylyk B; Abecassis J; Indra AK
    PLoS One; 2009; 4(4):e5367. PubMed ID: 19399189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
    Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
    Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
    Sterz CM; Kulle C; Dakic B; Makarova G; Böttcher MC; Bette M; Werner JA; Mandic R
    Oral Oncol; 2010 Feb; 46(2):116-22. PubMed ID: 20036607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
    Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
    Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma.
    Huang CF; Chen L; Li YC; Wu L; Yu GT; Zhang WF; Sun ZJ
    J Exp Clin Cancer Res; 2017 Sep; 36(1):116. PubMed ID: 28865486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma.
    Chen C; Wei Y; Hummel M; Hoffmann TK; Gross M; Kaufmann AM; Albers AE
    PLoS One; 2011 Jan; 6(1):e16466. PubMed ID: 21304586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. METTL3-mediated ALDH m
    Chen Z; Chen J; Xu X; Li Q; Zhang C; Li S; Liu L; Cao C; Chen D; He Q
    Oral Dis; 2024 Apr; 30(3):1061-1071. PubMed ID: 37249063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt.
    Kuo SZ; Blair KJ; Rahimy E; Kiang A; Abhold E; Fan JB; Wang-Rodriguez J; Altuna X; Ongkeko WM
    BMC Cancer; 2012 Nov; 12():556. PubMed ID: 23176396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer.
    Sayed SI; Dwivedi RC; Katna R; Garg A; Pathak KA; Nutting CM; Rhys-Evans P; Harrington KJ; Kazi R
    Oral Oncol; 2011 Apr; 47(4):237-43. PubMed ID: 21382740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Snail-induced epithelial-mesenchymal transition promotes cancer stem cell-like phenotype in head and neck cancer cells.
    Masui T; Ota I; Yook JI; Mikami S; Yane K; Yamanaka T; Hosoi H
    Int J Oncol; 2014 Mar; 44(3):693-9. PubMed ID: 24365974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.
    Chen YC; Chen YW; Hsu HS; Tseng LM; Huang PI; Lu KH; Chen DT; Tai LK; Yung MC; Chang SC; Ku HH; Chiou SH; Lo WL
    Biochem Biophys Res Commun; 2009 Jul; 385(3):307-13. PubMed ID: 19450560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
    Ortiz RC; Lopes NM; Amôr NG; Ponce JB; Schmerling CK; Lara VS; Moyses RA; Rodini CO
    J Oral Pathol Med; 2018 Sep; 47(8):740-747. PubMed ID: 29791975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
    Wu TF; Chen L; Bu LL; Gao J; Zhang WF; Jia J
    Eur J Pharm Sci; 2017 Apr; 101():243-250. PubMed ID: 28215944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.